HK1048636B - N-(吲羰基)哌嗪衍生物 - Google Patents

N-(吲羰基)哌嗪衍生物 Download PDF

Info

Publication number
HK1048636B
HK1048636B HK03100811.4A HK03100811A HK1048636B HK 1048636 B HK1048636 B HK 1048636B HK 03100811 A HK03100811 A HK 03100811A HK 1048636 B HK1048636 B HK 1048636B
Authority
HK
Hong Kong
Prior art keywords
formula
compound
group
indol
piperazin
Prior art date
Application number
HK03100811.4A
Other languages
English (en)
Chinese (zh)
Other versions
HK1048636A1 (en
Inventor
Bottcher Henning
Greiner Hartmut
Harting Jurgen
Bartoszyk Gerd
Seyfried Christoph
Van Amsterdam Christoph
Original Assignee
默克专利股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 默克专利股份公司 filed Critical 默克专利股份公司
Publication of HK1048636A1 publication Critical patent/HK1048636A1/xx
Publication of HK1048636B publication Critical patent/HK1048636B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
HK03100811.4A 1999-07-22 2000-07-07 N-(吲羰基)哌嗪衍生物 HK1048636B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19934433.7 1999-07-22
DE19934433A DE19934433A1 (de) 1999-07-22 1999-07-22 N-(Indolcarbonyl-)piperazinderivate
PCT/EP2000/006464 WO2001007435A2 (de) 1999-07-22 2000-07-07 N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden

Publications (2)

Publication Number Publication Date
HK1048636A1 HK1048636A1 (en) 2003-04-11
HK1048636B true HK1048636B (zh) 2006-08-11

Family

ID=7915702

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100811.4A HK1048636B (zh) 1999-07-22 2000-07-07 N-(吲羰基)哌嗪衍生物

Country Status (26)

Country Link
US (2) US6838461B1 (https=)
EP (1) EP1198453B9 (https=)
JP (2) JP5242871B2 (https=)
KR (1) KR100779207B1 (https=)
CN (1) CN1229345C (https=)
AR (1) AR024819A1 (https=)
AT (1) ATE236877T1 (https=)
AU (1) AU770411B2 (https=)
BR (1) BR0012607A (https=)
CA (1) CA2383779C (https=)
CZ (1) CZ300510B6 (https=)
DE (2) DE19934433A1 (https=)
DK (1) DK1198453T5 (https=)
ES (1) ES2192535T3 (https=)
HK (1) HK1048636B (https=)
HU (1) HUP0201988A3 (https=)
MX (1) MXPA02000730A (https=)
MY (1) MY122531A (https=)
NO (1) NO322154B1 (https=)
PL (1) PL201893B1 (https=)
PT (1) PT1198453E (https=)
RU (1) RU2251548C2 (https=)
SK (1) SK286066B6 (https=)
UA (1) UA73518C2 (https=)
WO (1) WO2001007435A2 (https=)
ZA (1) ZA200201486B (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
DE19934432A1 (de) * 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
DE10102053A1 (de) * 2001-01-17 2002-07-18 Merck Patent Gmbh Piperazinylcarbonylchinoline und -isochinoline
ES2268113T3 (es) * 2001-06-15 2007-03-16 F. Hoffmann-La Roche Ag Derivados de 4-piperazinilindol con afinidad al receptor 5-ht6.
CN1253220C (zh) * 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
DE10157673A1 (de) * 2001-11-24 2003-06-05 Merck Patent Gmbh Verwendung von N-(Indolcarbonyl-)piperazinderivaten
GB0203811D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
DE10217006A1 (de) 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
BR0313890A (pt) * 2002-08-30 2005-07-26 Becton Dickinson Co Método de controle da farmacocinética de compostos imunomoduladores
DE10246357A1 (de) * 2002-10-04 2004-04-15 Merck Patent Gmbh Verwendung von 5-HT2Rezeptorantagonisten
JP2007500251A (ja) * 2003-06-13 2007-01-11 ベクトン・ディキンソン・アンド・カンパニー 生物学的に活性な作用物質の改良型皮内送達
US20050180952A1 (en) * 2003-08-26 2005-08-18 Pettis Ronald J. Methods for intradermal delivery of therapeutics agents
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
EP1755605A2 (en) * 2004-04-15 2007-02-28 Samaritan Pharmaceuticals, Inc. Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease
EP1744784A2 (en) * 2004-05-11 2007-01-24 Becton, Dickinson and Company Formulations of anti-pain agents and methods of using the same
DE102004047517A1 (de) * 2004-09-28 2006-03-30 Merck Patent Gmbh Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid
SI1831159T1 (sl) * 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
GT200600042A (es) 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
KR20090017569A (ko) * 2006-05-05 2009-02-18 메르크 파텐트 게엠베하 결정질 (３-시아노-１ｈ-인돌-７-일)-[４-(４-플루오로펜에틸)피페라진-１-일]메탄온 포스페이트
US7514433B2 (en) * 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
ES2379848T3 (es) * 2007-05-14 2012-05-04 Sk Biopharmaceuticals Co., Ltd. Compuesto arilpiperazina arilalcanoil carbomoiloxi novedoso, composiciones farmacéuticas que comprenden el compuesto y método para tratar el dolor, ansiedad y depresión al administrar el compuesto
EP2008656A1 (en) * 2007-06-28 2008-12-31 Bergen Teknologioverforing AS Compositions for the treatment of hyperphenylalaninemia
JP5393677B2 (ja) * 2007-08-15 2014-01-22 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体
KR101062376B1 (ko) 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
US9308323B2 (en) 2011-11-15 2016-04-12 Smiths Medical Asd, Inc. Systems and methods for illuminated medical tubing detection and management indicating a characteristic of at least one infusion pump
RU2549963C1 (ru) * 2014-04-08 2015-05-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО "ДВГМУ" Минздрава России) Способ прогнозирования развития критической печеночной недостаточности на основании сывороточного уровня селена
SG11201807012QA (en) 2016-02-25 2018-09-27 Asceneuron S A Acid addition salts of piperazine derivatives
GB2554371B (en) * 2016-09-22 2019-10-09 Resolute Energy Solutions Ltd Well apparatus and associated methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3888269T2 (de) 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
US5093341A (en) 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5330986A (en) 1992-11-24 1994-07-19 Hoechst-Roussel Pharmaceuticals Inc. Indole-7-carboxamide derivatives
ZA954689B (en) 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
JP2001506230A (ja) 1996-08-09 2001-05-15 スミスクライン・ビーチャム・コーポレイション 新規ピペラジン含有化合物
GB9718712D0 (en) 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate
DE19934432A1 (de) * 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
US20070208811A1 (en) * 2004-04-07 2007-09-06 Matsushita Electric Industrial Co., Ltd. Information exchange support device, information exchange support method, and information exchange support program

Also Published As

Publication number Publication date
PT1198453E (pt) 2003-08-29
ZA200201486B (en) 2003-07-30
WO2001007435A3 (de) 2001-08-16
WO2001007435A2 (de) 2001-02-01
BR0012607A (pt) 2002-04-09
UA73518C2 (en) 2005-08-15
SK286066B6 (sk) 2008-02-05
KR20020019513A (ko) 2002-03-12
CA2383779A1 (en) 2001-02-01
HUP0201988A2 (hu) 2002-11-28
ES2192535T3 (es) 2003-10-16
DE50001729D1 (de) 2003-05-15
US20050096330A1 (en) 2005-05-05
EP1198453B1 (de) 2003-04-09
AU770411B2 (en) 2004-02-19
CZ300510B6 (cs) 2009-06-03
DE19934433A1 (de) 2001-01-25
DK1198453T5 (da) 2005-01-31
CN1229345C (zh) 2005-11-30
SK512002A3 (en) 2002-05-09
EP1198453A2 (de) 2002-04-24
MY122531A (en) 2006-04-29
AR024819A1 (es) 2002-10-23
DK1198453T3 (da) 2003-07-21
NO20020307D0 (no) 2002-01-21
NO20020307L (no) 2002-03-21
CA2383779C (en) 2011-03-29
ATE236877T1 (de) 2003-04-15
NO322154B1 (no) 2006-08-21
PL201893B1 (pl) 2009-05-29
US7084143B2 (en) 2006-08-01
JP2003505458A (ja) 2003-02-12
AU6270400A (en) 2001-02-13
JP5242871B2 (ja) 2013-07-24
JP2012006940A (ja) 2012-01-12
MXPA02000730A (es) 2002-08-20
EP1198453B9 (de) 2004-11-10
RU2251548C2 (ru) 2005-05-10
HK1048636A1 (en) 2003-04-11
CN1364157A (zh) 2002-08-14
HUP0201988A3 (en) 2003-12-29
PL353446A1 (en) 2003-11-17
US6838461B1 (en) 2005-01-04
KR100779207B1 (ko) 2007-11-27
CZ200268A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
CN1229345C (zh) N－(吲哚羰基)哌嗪衍生物
CN1093127C (zh) 哌嗪衍生物
CN1064358C (zh) 苄基哌啶衍生物
CN1244578C (zh) 取代的苯并呋喃－2－甲酰胺衍生物
CN1336924A (zh) 作为5－ht重吸收抑制剂和5－ht1b/1d配体的酰胺和脲衍生物
CN1729173A (zh) N－(吲哚乙基)环胺化合物
CN1177847C (zh) 作为5－ht2a拮抗剂的噁唑烷酮类化合物
CN1146549C (zh) 作为治疗活性化合物的磺酰基噁唑胺
HK1049161A1 (en) Indole derivatives
CN1726213A (zh) 作为腺苷a3受体配体的咪唑并喹啉衍生物
CN1768053A (zh) 吡唑化合物
CN1768056A (zh) 色烯酮吲哚
CN1170819C (zh) 哌啶醇
CN1076696A (zh) 药用化合物
CN1708303A (zh) 具有5－ht和血清素再摄取抑制作用的作为抗抑郁药和抗焦虑药的吡啶烷基－氨基烷基－1h－吲哚衍生物
CN1260791A (zh) 3－苄基哌啶类化合物
CN1349520A (zh) 用作5－羟色胺能药物的新型二唑衍生物
CN1043764C (zh) 作为5－ht1a拮抗剂的双环甲酰胺
CN1249055C (zh) 哌嗪基羰基喹啉和异喹啉
CN1304409A (zh) 用于治疗抑郁症的吲哚－3－基－环己胺衍生物(5－ht1受体拮抗剂)
CN1186346C (zh) 噻吩并吡咯烷酮
HK1019737A1 (en) Benzoxazinone dopamine d4 receptor antagonists
HK1061849B (en) Piperazinylcarbonylquinolines and-isoquinolines
HK1019737B (en) Benzoxazinone dopamine d4 receptor antagonists
HK1064378A (en) Substituted benzofuran-2-carboxamides derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110707